Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prisma Pharma is a pharmaceutical company based in Egypt that specializes in the development, marketing, and distribution of branded generic medications and nutritional supplements. The company focuses on several key therapeutic areas, including orthopedics, gastroenterology, and hematology, with well-known products such as Genuphil for joint health and Gastreg for gastrointestinal disorders. Prisma Pharma operates as a significant player in the Middle Eastern healthcare market, leveraging strategic partnerships for manufacturing and ensuring the availability of high-quality, affordable treatments. The company is recognized for its strong commercial presence and its commitment to expanding access to essential medicines in the region. It maintains a diverse portfolio of over 20 products aimed at addressing prevalent health conditions in its target markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prisma Pharma.